Supplemental material
Scandinavian Journal of Gastroenterology
Volume 54, 2019 - Issue 2
Articles
Proton pump inhibitor use is associated with elevated faecal calprotectin levels. A cross-sectional study on subjects referred for colonoscopy
, , , & 
Pontus KarlingDepartment of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden; Correspondence[email protected]
http://orcid.org/0000-0002-5607-0118View further author information
http://orcid.org/0000-0002-5607-0118View further author informationRelated Research Data
Antioxidant properties of omeprazole.
Source:
Published by Elsevier B.V.
An irritable bowel syndrome-specific symptom questionnaire: development and validation.
Source:
Informa UK Limited
Non-steroidal anti-inflammatory drug-induced enteropathy
Source:
Korean Association for the Study of Intestinal Diseases
Fecal calprotectin for mucosal healing
Source:
Wiley
Faecal calprotectin shedding after short-term treatment with non-steroidal anti-inflammatory drugs.
Source:
Informa UK Limited
Fecal Calprotectin Level Reflects the Severity of Clostridium difficile Infection
Source:
Korean Society for Laboratory Medicine (KAMJE)
Proton pump inhibitors are associated with elevation of faecal calprotectin and may affect specificity.
Source:
Ovid Technologies (Wolters Kluwer Health)
Lansoprazole inhibits oxygen-derived free radical production from neutrophils activated by Helicobacter pylori.
Source:
Ovid Technologies (Wolters Kluwer Health)
Prophylactic aspirin therapy does not increase faecal calprotectin concentrations.
Source:
Ovid Technologies (Wolters Kluwer Health)
A Link between Lifestyle Factors and Colorectal Cancer Risk
Source:
American Association for Cancer Research (AACR)
Proton pump inhibitors and gastroenteritis
Source:
Springer Science and Business Media LLC
Calprotectin in ankylosing spondylitis – frequently elevated in feces, but normal in serum
Source:
Informa UK Limited
Fecal Calprotectin Levels in Patients with Colonic Polyposis
Source:
Springer Science + Business Media
Clinical and histopathological correlations of fecal calprotectin release in colorectal carcinoma.
Source:
Baishideng Publishing Group Inc.
Low-dose aspirin-induced gastrointestinal diseases: past, present, and future.
Source:
Springer Science and Business Media LLC
Value of Fecal Calprotectin as a Biomarker for Juvenile Polyps in Children Investigated With Colonoscopy.
Source:
Ovid Technologies (Wolters Kluwer Health)
A quantitative analysis of NSAID-induced small bowel pathology by capsule enteroscopy.
Source:
Elsevier BV
Calprotectin in Daily Practice: Where Do We Stand in 2017?
Source:
S. Karger AG
Can chronic gastritis cause an increase in fecal calprotectin concentrations
Source:
Baishideng Publishing Group Inc.
Lansoprazole ameliorates intestinal mucosal damage induced by ischemia-reperfusion in rats
Source:
Baishideng Publishing Group Inc.
Fecal Calprotectin Predicts Relapse and Histological Mucosal Healing in Ulcerative Colitis.
Source:
Oxford University Press (OUP)
Linking provided by
